发明授权
- 专利标题: DERIVATIZED OLIGONUCLEOTIDES HAVING IMPROVED UPTAKE
- 专利标题(中): 衍生化寡核苷酸具有改进的记录资产的
-
申请号: EP92923139.7申请日: 1992-10-23
-
公开(公告)号: EP0724447B1公开(公告)日: 2003-05-07
- 发明人: MANOHARAN, Muthiah , COOK, Philip, Dan , BENNETT, Clarence Frank
- 申请人: ISIS PHARMACEUTICALS, INC.
- 申请人地址: 2280 Faraday Avenue Carlsbad, CA 92008 US
- 专利权人: ISIS PHARMACEUTICALS, INC.
- 当前专利权人: ISIS PHARMACEUTICALS, INC.
- 当前专利权人地址: 2280 Faraday Avenue Carlsbad, CA 92008 US
- 代理机构: Hallybone, Huw George
- 优先权: US782374 19911024
- 国际公布: WO93007883 19930429
- 主分类号: A61K31/70
- IPC分类号: A61K31/70 ; C07H21/00
摘要:
Linked nucleosides having at least one functionalized nucleoside that bears a substituent such as a steroid molecule, a reporter molecule, a non-aromatic lipophilic molecule, a reporter enzyme, a peptide, a protein, a water soluble vitamin, a lipid soluble vitamin, an RNA cleaving complex, a metal chelator, a porphyrin, an alkylator, a pyrene, a hybrid photonuclease/intercalator, or an aryl azide photo-crosslinking agent exhibit increased cellular uptake and other properties. The substituent can be attached at the 2'-position of the functionalized nucleoside via a linking group. If at least a portion of the remaining linked nucleosides are 2'-deoxy-2'-fluoro, 2'-O-methoxy, 2'-O-ethoxy, 2'-O-propoxy, 2'-O-aminoalkoxy or 2'-O-allyloxy nucleosides, the substituent can be attached via a linking group at any of the 3' or the 5' positions of the nucleoside or on the heterocyclic base of the nucleoside or on the inter-nucleotide linkage linking the nucleoside to an adjacent nucleoside.
信息查询